These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26541133)

  • 1. Characterization of immune response to novel HLA-A2-restricted epitopes from zinc transporter 8 in type 1 diabetes.
    Xu X; Gu Y; Bian L; Shi Y; Cai Y; Chen Y; Chen H; Qian L; Wu X; Xu K; Mallone R; Davidson HW; Yu L; She J; Zhang M; Yang T
    Vaccine; 2016 Feb; 34(6):854-62. PubMed ID: 26541133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays.
    Wu X; Xu X; Gu R; Wang Z; Chen H; Xu K; Zhang M; Hutton J; Yang T
    Autoimmunity; 2012 Mar; 45(2):176-85. PubMed ID: 22260783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc transporter (ZnT)8(186-194) is an immunodominant CD8+ T cell epitope in HLA-A2+ type 1 diabetic patients.
    Scotto M; Afonso G; Larger E; Raverdy C; Lemonnier FA; Carel JC; Dubois-Laforgue D; Baz B; Levy D; Gautier JF; Launay O; Bruno G; Boitard C; Sechi LA; Hutton JC; Davidson HW; Mallone R
    Diabetologia; 2012 Jul; 55(7):2026-31. PubMed ID: 22526607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZnT8 is a major CD8+ T cell-recognized autoantigen in pediatric type 1 diabetes.
    Énée É; Kratzer R; Arnoux JB; Barilleau E; Hamel Y; Marchi C; Beltrand J; Michaud B; Chatenoud L; Robert JJ; van Endert P
    Diabetes; 2012 Jul; 61(7):1779-84. PubMed ID: 22586580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel HLA-A 0201-restricted cytotoxic T lymphocyte epitopes from Zinc Transporter 8.
    Li S; Li H; Chen B; Lu D; Deng W; Jiang Y; Zhou Z; Yang Z
    Vaccine; 2013 Mar; 31(12):1610-5. PubMed ID: 23246542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet-specific CTL cloned from a type 1 diabetes patient cause beta-cell destruction after engraftment into HLA-A2 transgenic NOD/scid/IL2RG null mice.
    Unger WW; Pearson T; Abreu JR; Laban S; van der Slik AR; der Kracht SM; Kester MG; Serreze DV; Shultz LD; Griffioen M; Drijfhout JW; Greiner DL; Roep BO
    PLoS One; 2012; 7(11):e49213. PubMed ID: 23155466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes.
    Corbet S; Nielsen HV; Vinner L; Lauemoller S; Therrien D; Tang S; Kronborg G; Mathiesen L; Chaplin P; Brunak S; Buus S; Fomsgaard A
    J Gen Virol; 2003 Sep; 84(Pt 9):2409-2421. PubMed ID: 12917462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice.
    Enée E; Martinuzzi E; Blancou P; Bach JM; Mallone R; van Endert P
    J Immunol; 2008 Apr; 180(8):5430-8. PubMed ID: 18390725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DCs pulsed with novel HLA-A2-restricted CTL epitopes against hepatitis C virus induced a broadly reactive anti-HCV-specific T lymphocyte response.
    Guo Z; Zhang H; Rao H; Jiang D; Cong X; Feng B; Wang J; Wei L; Chen H
    PLoS One; 2012; 7(6):e38390. PubMed ID: 22701633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation Initiative.
    Mallone R; Scotto M; Janicki CN; James EA; Fitzgerald-Miller L; Wagner R; Gottlieb P; Thorpe J; Jospe N; Durinovic-Bellò I; Boitard C; Lou O; Dayan CM; Wong FS;
    Diabetes Metab Res Rev; 2011 Nov; 27(8):720-6. PubMed ID: 22069251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective CD8
    Ma Y; Tang K; Zhang Y; Zhang C; Cheng L; Zhang F; Zhuang R; Jin B; Zhang Y
    Virol J; 2020 Oct; 17(1):146. PubMed ID: 33028368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivo.
    Tu SH; Huang HI; Lin SI; Liu HY; Sher YP; Chiang SK; Chong P; Roffler S; Tseng GC; Chen HW; Liu SJ
    J Immunother; 2012 Apr; 35(3):235-44. PubMed ID: 22421941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8.
    Dang M; Rockell J; Wagner R; Wenzlau JM; Yu L; Hutton JC; Gottlieb PA; Davidson HW
    J Immunol; 2011 May; 186(10):6056-63. PubMed ID: 21471440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond HLA-A*0201: new HLA-transgenic nonobese diabetic mouse models of type 1 diabetes identify the insulin C-peptide as a rich source of CD8+ T cell epitopes.
    Antal Z; Baker JC; Smith C; Jarchum I; Babad J; Mukherjee G; Yang Y; Sidney J; Sette A; Santamaria P; DiLorenzo TP
    J Immunol; 2012 Jun; 188(11):5766-75. PubMed ID: 22539795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-B7-restricted islet epitopes are differentially recognized in type 1 diabetic children and adults and form weak peptide-HLA complexes.
    Scotto M; Afonso G; Østerbye T; Larger E; Luce S; Raverdy C; Novelli G; Bruno G; Gonfroy-Leymarie C; Launay O; Lemonnier FA; Buus S; Carel JC; Boitard C; Mallone R
    Diabetes; 2012 Oct; 61(10):2546-55. PubMed ID: 22997432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of HLA-A2-restricted immunogenic peptides derived from Vitamin D-Binding Protein.
    Zhang M; Lu G; Meng F; Li S; Li X; Gong X
    Cell Immunol; 2018 Jun; 328():18-23. PubMed ID: 29549963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZnT8
    Zhang M; Zhou Z; Wang J; Li S
    Immunol Lett; 2016 Dec; 180():66-72. PubMed ID: 27832962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice.
    Peng S; Trimble C; He L; Tsai YC; Lin CT; Boyd DA; Pardoll D; Hung CF; Wu TC
    Gene Ther; 2006 Jan; 13(1):67-77. PubMed ID: 16107858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8+ T cells specific for the androgen receptor are common in patients with prostate cancer and are able to lyse prostate tumor cells.
    Olson BM; McNeel DG
    Cancer Immunol Immunother; 2011 Jun; 60(6):781-92. PubMed ID: 21350948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccine.
    Seyed N; Taheri T; Vauchy C; Dosset M; Godet Y; Eslamifar A; Sharifi I; Adotevi O; Borg C; Rohrlich PS; Rafati S
    PLoS One; 2014; 9(10):e108848. PubMed ID: 25310094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.